Executive Vice President of Amgen sells 30501 shares in insider sale

Esteban Santos, the Executive Vice President of $AMGN, recently sold 30,501 shares of the company on the 26th of February, 2026, for an approximate amount of $11,563,456. This transaction, which accounted for about 28.5% of the shares of this class of stock, was disclosed in a recent filing with the Securities and Exchange Commission (SEC). Following this sale, Santos still retains ownership of 76,618 shares of $AMGN stock.

Over the past six months, insiders at $AMGN have engaged in trading activity seven times, with all trades being sales and no purchases. Esteban Santos, in addition to the recent sale, has also made another sale, totaling 54,792 shares and amounting to an estimated $20,772,595. Murdo Gordon, Executive Vice President of Global Commercial Operations, sold 6,879 shares for approximately $2,317,071. Nancy A. Grygiel, Senior Vice President and Chief Compliance Officer, has conducted two sales of 3,139 shares, totaling $1,058,666. Matthew C. Busch, Vice President of Finance and Chief Accounting Officer, sold 1,000 shares for around $375,790, while Rachna Khosla, Senior Vice President of Business Development, sold 890 shares for about $299,255.

In terms of hedge fund activity, 1,422 institutional investors have added shares of $AMGN stock to their portfolios, while 1,324 have decreased their positions in the most recent quarter. Some notable recent moves include UBS Asset Management Americas LLC removing 13,593,173 shares (representing a 74.7% decrease) from their portfolio, with an estimated value of $4,449,181,454. Capital World Investors added 4,302,237 shares (a 22.9% increase) to their portfolio, valued at $1,408,165,192. JPMorgan Chase & Co removed 1,936,240 shares (a 45.8% decrease) from their portfolio, with an estimated worth of $633,750,714. Rockefeller Capital Management L.P. added 1,785,595 shares (a substantial 354.6% increase) to their portfolio, valued at $584,443,099. Charles Schwab Investment Management Inc removed 1,739,567 shares (a 12.8% decrease) from their portfolio, with an estimated value of $569,377,674. Pacer Advisors, Inc. removed all 1,613,121 shares from their portfolio, with an estimated worth of $527,990,634. BlackRock, Inc. added 1,361,706 shares (a 3.0% increase) to their portfolio, valued at $445,699,990.

In the fourth quarter of 2025, $AMGN reported revenues of $9.9 billion, reflecting an 8.58% increase from the same period the previous year. Congressional members have traded $AMGN stock eight times in the past six months, with three purchases and five sales. Representative David Taylor conducted four trades, including one purchase of up to $15,000 and three sales worth up to $45,000. Representative Marjorie Taylor Greene made two purchases worth up to $30,000 each and no sales. Representative Lisa C. McClain sold up to $15,000 on one occasion, while Senator Sheldon Whitehouse sold up to $15,000 on another.

Various Wall Street analysts have recently issued reports on $AMGN, with two firms issuing buy ratings and one firm issuing a sell rating. Some recent analyst ratings include an “Outperform” rating from BMO Capital, an “Overweight” rating from Piper Sandler, and an “Underperform” rating from B of A Securities. Multiple analysts have also provided price targets for $AMGN, with a median target of $350.0. Recent target prices set by analysts include $350.0 by Emily Field from Barclays, $375.0 by Mohit Bansal from Wells Fargo, $432.0 by David Amsellem from Piper Sandler, $347.0 by Vamil Divan from Guggenheim, $400.0 by Jasper Hellweg from Argus Research, $355.0 by David Risinger from Leerink Partners, and $345.0 by Geoff Meacham from Citigroup.

It is important to note that this article does not constitute financial advice, and readers are encouraged to refer to Quiver Quantitative’s disclaimers for further information on the subject.